Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.
scientific article published on 16 November 2015
Author/s
author: Sagar Lonial, Kenneth C. Anderson, Philippe Moreau, Paul G. Richardson, Thierry Facon, Donna E Reece, Sundar Jagannath, Ravi Vij, Lotfi Benboubker, Jeffrey A Zonder, Eric Bleickardt, Sagar Lonial, Marc S Raab, Andrzej Jakubowiak
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.